Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial evaluating the efficacy and safety of nanosomal docetaxel lipid suspension in patients with triple-negative breast cancer is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Nanosomal Docetaxel Lipid Suspension (docetaxel lipid suspension)

Snippet

Sponsor: Jina Pharmaceuticals Inc. | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: RECRUITING